Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Atkinson

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Journal of the American Chemical Society|February 24, 2017
Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein ReceptorCarlos A Sanhueza, Michael M Baksh, Benjamin Thuma, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
British Journal of Sports Medicine|February 8, 2023
Consensus on a netball video analysis framework of descriptors and definitions by the netball video analysis consensus groupLois Mackay, Ben Jones, Dina Christina Christa Janse van Rensburg, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2010
Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distributionJeffrey A Pfefferkorn, John Litchfield, Richard Hutchings, et al.
Obesity (Silver Spring, Md.)|July 14, 2021
Changes in mood and health-related quality of life in Look AHEAD 6 years after termination of the lifestyle intervention, Thomas A Wadden, Ariana M Chao, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Journal of the American Chemical Society|February 24, 2017
Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein ReceptorCarlos A Sanhueza, Michael M Baksh, Benjamin Thuma, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
British Journal of Sports Medicine|February 8, 2023
Consensus on a netball video analysis framework of descriptors and definitions by the netball video analysis consensus groupLois Mackay, Ben Jones, Dina Christina Christa Janse van Rensburg, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2010
Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distributionJeffrey A Pfefferkorn, John Litchfield, Richard Hutchings, et al.
Obesity (Silver Spring, Md.)|July 14, 2021
Changes in mood and health-related quality of life in Look AHEAD 6 years after termination of the lifestyle intervention, Thomas A Wadden, Ariana M Chao, et al.
Pageof 6